Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Behcet's Disease
NCT01441076Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Sep 2011
- Primary completion
- Oct 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label trial of anakinra in Behcet's disease (BD), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Primary endpoint: Clinical Remission. Started Sep 2011; status: completed.
02
Drugs
anakinra
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT01441076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441076.